Tom Diacovo

Biography
Thomas Diacovo, M.D., is an internationally recognized leader in thrombosis research. Diacovo has led the development of pharmacological agents and devices specifically designed for neonatal intensive care patients, in particular those with congenital heart disease who are at high risk for forming blood clots. His research team was the first to conduct a clinical trial using a new agent designed to prevent blood clots in an artificial conduit placed during surgery to establish essential blood flow to the lungs of newborns with single ventricle physiology. Diacovo joined Children’s Hospital from Columbia University Medical Center where he was a professor of pediatrics, pathology and cell biology and served as director of Newborn Research and associate director of Neonatology. He has has been a National Institutes of Health-funded investigator for over 20 years, with projects that shed insight into inflammation, malignancies and blood clots.